Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Quinoline. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110606830B reveals a water-based method for piperaquine intermediates achieving >99.5% purity with simplified mother liquor reuse for cost efficiency.
Novel one-step synthesis of imidazopyridine cores with antioxidant potential. Efficient catalyst-free process for pharmaceutical intermediates.
Patent CN110845410B reveals a safe one-pot method for 6,7-dimethoxy-3,4-dihydroisoquinoline HCl using phosphotungstic acid, offering high purity and cost reduction.
Patent CN109608488A reveals Ru-catalyzed route for quinoline derivatives. Offers cost reduction and scalable supply chain solutions for global pharmaceutical intermediates.
Novel low-temperature process for high-purity imiquimod intermediates using phthalimide protection, offering significant cost reduction and scalability for pharmaceutical manufacturing.
Patent CN106496118B reveals high-purity quinoline synthesis. Enables cost reduction in pharma intermediate manufacturing with scalable mild conditions.
Advanced synthesis of 3-cyano-4-chloro-6-amino-7-ethoxyquinoline offers cost reduction in pharmaceutical manufacturing. Reliable supplier for high-purity intermediates.
Patent CN116789664A details a metal-free photocatalytic route for trifluoromethyl benzimidazoloisoquinoline analogues, offering cost-effective and scalable manufacturing solutions.
Novel quinoline salt dearomatization patent enables high-purity pharmaceutical intermediates. Discover cost-effective scalable synthesis routes for complex bridged polycyclic structures.
Discover the novel synthesis of 1-R-4-amino-1,2,3,4-tetrahydroquinoline from 4-hydroxyquinoline. A scalable, cost-effective route for API intermediates avoiding harsh Friedel-Crafts conditions.
Novel synthesis of Roxadustat intermediate via m-bromobenzaldehyde. High yield, eco-friendly process suitable for industrial scale-up and cost reduction.
Patent CN102267944A reveals a cost-effective route for Dimemorfan Phosphate intermediates using commodity raw materials, ensuring high purity and supply stability.
Patent CN103254108B reveals a novel pyrrole synthesis route offering high purity and simplified processing for reliable pharmaceutical intermediates supply chains.
Patent CN115197139A reveals a green, high-yield route for Roxadustat intermediates. Discover cost-effective manufacturing and supply chain advantages.
Patent CN1139575C details a mild photooxidation route for quinoline-5,8-diones, offering safer manufacturing and cost reduction in pharmaceutical intermediate production.
Patent CN110606855B reveals a novel Cu-catalyzed synthesis for benzothienoisoquinoline derivatives. Discover cost-effective, scalable manufacturing solutions for high-purity pharmaceutical intermediates.
Novel metal-free synthesis method for quinoline-2-xanthate. Offers mild conditions, high yield, and supply chain stability for pharmaceutical intermediates.
Patent CN113979937A reveals a novel photocatalytic route for quinoline derivatives, eliminating strong oxidants to reduce equipment corrosion and lower manufacturing costs.
Patent CN102503887B reveals a mild AgOTf-catalyzed route to isoquinolines. This method offers cost reduction in API manufacturing and reliable supply chain solutions.
Novel metal-free route for 4-arylquinolines using DMSO and formaldehyde. High yield, scalable process for pharmaceutical intermediates.